Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 24,400 shares at $104.42 ($2.6M) on 2020-04-20, disclosed to the SEC on 2020-05-21.
Seasonal sale ($2.6M) by Director — this insider has traded RGEN in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.42 | 8,998 | $940K | 36.8% |
| 2 | $104.42 | 8,998 | $940K | 36.8% |
| 3 | $104.98 | 3,202 | $336K | 13.2% |
| 4 | $104.98 | 3,202 | $336K | 13.2% |
| Total | $104.57 avg | 24,400 | $2.6M | 100% |
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |